Antibody-Drug Conjugates
compound
Antibody-drug conjugates (ADCs) are targeted cancer therapies that combine an antibody specific to cancer cells with a cytotoxic drug. The antibody component allows for precise delivery of the drug to cancer cells, minimizing damage to healthy cells. This targeted approach is significant for longevity and health optimization as it offers a more effective and less toxic cancer treatment option.
Updated 8/5/2026
Daratumumab
compound
Daratumumab is a monoclonal antibody targeting CD38, a protein highly expressed on the surface of multiple myeloma cells. It works by inducing cell death through immune-mediated mechanisms and direct apoptosis, making it a valuable treatment in oncology. Its relevance to longevity and health optimization lies in its potential to modulate the immune system and target cancerous cells, although its primary use is currently in cancer therapy.
Updated 8/5/2026
DC Vaccination
compound
DC vaccination, or dendritic cell vaccination, involves using dendritic cells to stimulate the immune system to target specific antigens, often used in cancer immunotherapy. This approach leverages the body's natural immune response to enhance the detection and destruction of cancer cells, potentially contributing to longevity by improving cancer treatment outcomes.
Updated 8/5/2026
Delgocitinib
compound
Delgocitinib is a Janus kinase (JAK) inhibitor primarily used for its immunomodulatory effects, particularly in treating inflammatory skin conditions like atopic dermatitis. By inhibiting JAK pathways, it reduces inflammation and immune response, which is crucial for managing chronic inflammatory conditions that can impact longevity and overall health.
Updated 8/5/2026
Lenalidomide
compound
Lenalidomide is an immunomodulatory drug primarily used in the treatment of multiple myeloma and certain other hematological disorders. It works by modulating the immune system and inhibiting angiogenesis, which can help in controlling cancer growth. Its relevance to longevity and health optimization lies in its potential to modulate immune function, which is crucial for maintaining health and preventing age-related diseases.
Updated 8/5/2026
Piclidenoson
compound
Piclidenoson is an adenosine A3 receptor agonist that modulates immune responses and has potential anti-inflammatory effects. It is being investigated for its role in treating autoimmune diseases, which could contribute to longevity by reducing chronic inflammation and immune system dysregulation.
Updated 8/5/2026
Recaticimab
compound
Recaticimab is a novel monoclonal antibody that targets specific immune pathways to modulate immune responses. Its primary mechanism involves altering immune cell activity, which may have implications for treating autoimmune conditions and enhancing immune resilience. This compound is relevant for longevity and health optimization as it could potentially reduce chronic inflammation and improve immune system function.
Updated 8/5/2026
SPOT-mRNA01
compound
SPOT-mRNA01 is an emerging mRNA-based therapy designed to modulate immune responses. Its primary mechanism involves using synthetic mRNA to instruct cells to produce specific proteins that can enhance or regulate immune function. This approach holds potential for longevity and health optimization by potentially improving immune resilience and targeting age-related immune decline.
Updated 8/5/2026
Teclistamab
compound
Teclistamab is a bispecific antibody that targets BCMA (B-cell maturation antigen) and CD3, facilitating the immune system's ability to attack multiple myeloma cells. It represents a novel approach in cancer immunotherapy, potentially enhancing immune response against cancer cells, which is crucial for improving longevity and health outcomes in patients with multiple myeloma.
Updated 8/5/2026
Thymosin Alpha-1
compound
Thymosin Alpha-1 is a peptide that plays a role in modulating the immune system by enhancing T-cell function and promoting the maturation of immune cells. It is considered for its potential to boost immune response, which is crucial for longevity and health optimization, especially in aging populations where immune function tends to decline.
Updated 7/14/2026